|
ADYX
|
Adynxx Inc
|
US
|
OTC
|
|
AKRO
|
Akero Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APLT
|
Applied Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ARMP
|
Armata Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
ATHE
|
Alterity Therapeutics Limited
|
US
|
NASDAQ
|
|
AXLA
|
Axcella Health Inc.
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
US
|
NASDAQ
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
US
|
NASDAQ
|
|
CABA
|
Cabaletta Bio, Inc.
|
US
|
NASDAQ
|
|
CLGN
|
CollPlant Holdings, Ltd.
|
US
|
NASDAQ
|
|
CNTG
|
Centogene N.V.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
CYCN
|
Cyclerion Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DMTK
|
DermTech, Inc.
|
US
|
NASDAQ
|
|
DTIL
|
Precision BioSciences, Inc.
|
US
|
NASDAQ
|
|
EDSA
|
Edesa Biotech, Inc.
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|